Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis

Clinical trial NCT00030966 · COMPLETED

Trial details

NCT number: NCT00030966
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2002-01-01
Primary completion: 2005-04-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.